vs
Side-by-side financial comparison of MANGOCEUTICALS, INC. (MGRX) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $94.4K, roughly 807.3× MANGOCEUTICALS, INC.). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs -2935.1%, a 2942.5% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs -10.3%). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs -33.6%).
MANGOCEUTICALS, INC. is a men's health and personal care company that develops, manufactures, and distributes science-backed consumer products, including dietary supplements, skincare, and hair care solutions targeted at common male wellness needs. It mainly operates in the U.S. market, selling via direct-to-consumer e-commerce platforms and select retail partners, prioritizing accessible, transparent wellness offerings for adult male consumers.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
MGRX vs VMD — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $94.4K | $76.2M |
| Net Profit | $-2.8M | $5.6M |
| Gross Margin | 50.3% | 57.9% |
| Operating Margin | -389.7% | 11.0% |
| Net Margin | -2935.1% | 7.4% |
| Revenue YoY | -10.3% | 25.5% |
| Net Profit YoY | -42.1% | 30.7% |
| EPS (diluted) | $0.38 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $94.4K | $76.2M | ||
| Q3 25 | $84.2K | $71.9M | ||
| Q2 25 | $168.1K | $63.1M | ||
| Q1 25 | $109.3K | $59.1M | ||
| Q4 24 | $105.2K | $60.7M | ||
| Q3 24 | $133.4K | $58.0M | ||
| Q2 24 | $163.2K | $55.0M | ||
| Q1 24 | $214.1K | $50.6M |
| Q4 25 | $-2.8M | $5.6M | ||
| Q3 25 | $-7.6M | $3.5M | ||
| Q2 25 | $-5.4M | $3.2M | ||
| Q1 25 | $-4.8M | $2.6M | ||
| Q4 24 | $-1.9M | $4.3M | ||
| Q3 24 | $-2.0M | $3.9M | ||
| Q2 24 | $-2.4M | $1.5M | ||
| Q1 24 | $-2.4M | $1.6M |
| Q4 25 | 50.3% | 57.9% | ||
| Q3 25 | 60.4% | 57.5% | ||
| Q2 25 | 53.5% | 58.3% | ||
| Q1 25 | 56.8% | 56.3% | ||
| Q4 24 | 76.1% | 59.5% | ||
| Q3 24 | 62.0% | 59.3% | ||
| Q2 24 | 42.8% | 59.8% | ||
| Q1 24 | 68.8% | 58.9% |
| Q4 25 | -389.7% | 11.0% | ||
| Q3 25 | -8953.5% | 7.8% | ||
| Q2 25 | -3134.0% | 8.1% | ||
| Q1 25 | -4440.0% | 6.5% | ||
| Q4 24 | -1594.0% | 10.6% | ||
| Q3 24 | -1318.2% | 9.7% | ||
| Q2 24 | -1329.1% | 6.6% | ||
| Q1 24 | -1105.9% | 4.4% |
| Q4 25 | -2935.1% | 7.4% | ||
| Q3 25 | -9042.8% | 4.9% | ||
| Q2 25 | -3221.6% | 5.0% | ||
| Q1 25 | -4427.4% | 4.4% | ||
| Q4 24 | -1851.2% | 7.1% | ||
| Q3 24 | -1499.0% | 6.7% | ||
| Q2 24 | -1465.4% | 2.7% | ||
| Q1 24 | -1105.9% | 3.2% |
| Q4 25 | $0.38 | $0.14 | ||
| Q3 25 | $-0.69 | $0.09 | ||
| Q2 25 | $-0.57 | $0.08 | ||
| Q1 25 | $-1.29 | $0.06 | ||
| Q4 24 | $-0.79 | $0.10 | ||
| Q3 24 | $-1.14 | $0.10 | ||
| Q2 24 | $-1.37 | $0.04 | ||
| Q1 24 | $-1.50 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.5M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.2M | $141.5M |
| Total Assets | $16.1M | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.5M | $13.5M | ||
| Q3 25 | $481.3K | $11.1M | ||
| Q2 25 | $101.0K | $20.0M | ||
| Q1 25 | $76.5K | $10.2M | ||
| Q4 24 | $58.7K | $17.5M | ||
| Q3 24 | $73.9K | $11.3M | ||
| Q2 24 | $490.2K | $8.8M | ||
| Q1 24 | $15.3K | $7.3M |
| Q4 25 | $15.2M | $141.5M | ||
| Q3 25 | $15.7M | $133.6M | ||
| Q2 25 | $19.2M | $139.7M | ||
| Q1 25 | $20.3M | $134.8M | ||
| Q4 24 | $13.9M | $131.4M | ||
| Q3 24 | $13.4M | $125.0M | ||
| Q2 24 | $13.8M | $119.4M | ||
| Q1 24 | $-958.4K | $116.3M |
| Q4 25 | $16.1M | $199.2M | ||
| Q3 25 | $16.5M | $202.4M | ||
| Q2 25 | $20.8M | $184.6M | ||
| Q1 25 | $21.8M | $178.1M | ||
| Q4 24 | $15.4M | $177.1M | ||
| Q3 24 | $14.8M | $169.5M | ||
| Q2 24 | $15.2M | $163.9M | ||
| Q1 24 | $301.4K | $154.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.1M | $18.4M |
| Free Cash FlowOCF − Capex | — | $9.7M |
| FCF MarginFCF / Revenue | — | 12.7% |
| Capex IntensityCapex / Revenue | — | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | — | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.1M | $18.4M | ||
| Q3 25 | $-1.2M | $18.4M | ||
| Q2 25 | $-1.3M | $12.3M | ||
| Q1 25 | $-2.3M | $2.9M | ||
| Q4 24 | $-1.1M | $15.0M | ||
| Q3 24 | $-1.2M | $12.7M | ||
| Q2 24 | $-1.6M | $10.2M | ||
| Q1 24 | $-991.1K | $1.2M |
| Q4 25 | — | $9.7M | ||
| Q3 25 | — | $10.7M | ||
| Q2 25 | — | $4.1M | ||
| Q1 25 | — | $-12.6M | ||
| Q4 24 | — | $3.2M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-4.8M |
| Q4 25 | — | 12.7% | ||
| Q3 25 | — | 14.9% | ||
| Q2 25 | — | 6.5% | ||
| Q1 25 | — | -21.4% | ||
| Q4 24 | — | 5.2% | ||
| Q3 24 | — | 3.0% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | -9.5% |
| Q4 25 | — | 11.5% | ||
| Q3 25 | — | 10.6% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 26.2% | ||
| Q4 24 | — | 19.5% | ||
| Q3 24 | — | 19.0% | ||
| Q2 24 | — | 16.3% | ||
| Q1 24 | — | 11.9% |
| Q4 25 | — | 3.27× | ||
| Q3 25 | — | 5.23× | ||
| Q2 25 | — | 3.88× | ||
| Q1 25 | — | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | — | 6.94× | ||
| Q1 24 | — | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
